Bruns C - Search Results

1

SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile.

Bruns C, Lewis I, Briner U, Meno-Tetang G, Weckbecker G. Bruns C, et al. Eur J Endocrinol. 2002 May;146(5):707-16. doi: 10.1530/eje.0.1460707. Eur J Endocrinol. 2002. PMID: 11980628

2

A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.

Lewis I, Bauer W, Albert R, Chandramouli N, Pless J, Weckbecker G, Bruns C. Lewis I, et al. Among authors: bruns c. J Med Chem. 2003 Jun 5;46(12):2334-44. doi: 10.1021/jm021093t. J Med Chem. 2003. PMID: 12773038

3

SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone/insulin-like growth factor-I axis in rats, primates, and dogs.

Weckbecker G, Briner U, Lewis I, Bruns C. Weckbecker G, et al. Among authors: bruns c. Endocrinology. 2002 Oct;143(10):4123-30. doi: 10.1210/en.2002-220219. Endocrinology. 2002. PMID: 12239124

4

Characterization of somatostatin receptor subtypes.

Bruns C, Weckbecker G, Raulf F, Lübbert H, Hoyer D. Bruns C, et al. Ciba Found Symp. 1995;190:89-101; discussion 101-10. doi: 10.1002/9780470514733.ch6. Ciba Found Symp. 1995. PMID: 7587655 Review.

5

Somatostatin analogues for somatostatin-receptor-mediated radiotherapy of cancer.

Stolz B, Smith-Jones P, Albert R, Tolcsvai L, Briner U, Ruser G, Mäcke H, Weckbecker G, Bruns C. Stolz B, et al. Among authors: bruns c. Digestion. 1996;57 Suppl 1:17-21. doi: 10.1159/000201387. Digestion. 1996. PMID: 8813461

6

Somatostatin receptors and the potential use of Sandostatin to interfere with vascular remodelling.

Bruns C, Shi V, Hoyer D, Schuurman H, Weckbecker G. Bruns C, et al. Eur J Endocrinol. 2000 Oct;143 Suppl 1:S3-7. doi: 10.1530/eje.0.143s003. Eur J Endocrinol. 2000. PMID: 11068933 Review.

7

Regulation of CRH-induced secretion of ACTH and corticosterone by SOM230 in rats.

Silva AP, Schoeffter P, Weckbecker G, Bruns C, Schmid HA. Silva AP, et al. Among authors: bruns c. Eur J Endocrinol. 2005 Sep;153(3):R7-R10. doi: 10.1530/eje.1.01998. Eur J Endocrinol. 2005. PMID: 16131595

8

Opportunities in somatostatin research: biological, chemical and therapeutic aspects.

Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C. Weckbecker G, et al. Among authors: bruns c. Nat Rev Drug Discov. 2003 Dec;2(12):999-1017. doi: 10.1038/nrd1255. Nat Rev Drug Discov. 2003. PMID: 14654798 Review. No abstract available.

9

A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients.

van der Hoek J, de Herder WW, Feelders RA, van der Lely AJ, Uitterlinden P, Boerlin V, Bruns C, Poon KW, Lewis I, Weckbecker G, Krahnke T, Hofland LJ, Lamberts SW. van der Hoek J, et al. Among authors: bruns c. J Clin Endocrinol Metab. 2004 Feb;89(2):638-45. doi: 10.1210/jc.2003-031052. J Clin Endocrinol Metab. 2004. PMID: 14764775 Free article. Clinical Trial.

10

The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.

Hofland LJ, van der Hoek J, van Koetsveld PM, de Herder WW, Waaijers M, Sprij-Mooij D, Bruns C, Weckbecker G, Feelders R, van der Lely AJ, Beckers A, Lamberts SW. Hofland LJ, et al. Among authors: bruns c. J Clin Endocrinol Metab. 2004 Apr;89(4):1577-85. doi: 10.1210/jc.2003-031344. J Clin Endocrinol Metab. 2004. PMID: 15070915 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

873 results

Search Page